AU7488381A - Insulin analogues - Google Patents
Insulin analoguesInfo
- Publication number
- AU7488381A AU7488381A AU74883/81A AU7488381A AU7488381A AU 7488381 A AU7488381 A AU 7488381A AU 74883/81 A AU74883/81 A AU 74883/81A AU 7488381 A AU7488381 A AU 7488381A AU 7488381 A AU7488381 A AU 7488381A
- Authority
- AU
- Australia
- Prior art keywords
- des
- insulin
- denotes
- ala
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 6
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 102000000496 Carboxypeptidases A Human genes 0.000 abstract 1
- 108010080937 Carboxypeptidases A Proteins 0.000 abstract 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
1. Claims for Contracting States : BE, LI, DE, FR, GB, IT, NL, SE Insulin of the formula I see diagramm : EP0046979,P10,F1 in which X denotes Thr or OH and Y denotes Asp or Asn. 1. Claims for Contracting States : AT A process for the preparation of an insulin of the formula I, see diagramm : EP0046979,P12,F1 in which X denotes Thr or OH and Y denotes Asp or Asn, which comprises a) converting human insulin, desamido**A21 -human insulin, des-Thr**B30 -human insulin, desamido**A21 -des-Thr**B30 -human insulin, des-Ala**B30 -swine insulin or desamido**A21 - des-Ala**B30 swine insulin into the N**alpha AI -N**vepsiln B29 -bis-Boc compound and subjecting this to Edman degradation, b) treating des-Phe**BI -human insulin or des-Phe**BI -des-Ala**B20 -swine insulin with acid, or c) treating a compound of the formula I in which X denotes Ala with carboxypeptidase A.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803033127 DE3033127A1 (en) | 1980-09-03 | 1980-09-03 | NEW INSULIN ANALOG |
DE30331272 | 1980-09-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7488381A true AU7488381A (en) | 1982-03-11 |
AU545399B2 AU545399B2 (en) | 1985-07-11 |
Family
ID=6111025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74883/81A Ceased AU545399B2 (en) | 1980-09-03 | 1981-09-02 | Insulin analogues |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0046979B1 (en) |
JP (1) | JPS5777655A (en) |
AT (1) | ATE4591T1 (en) |
AU (1) | AU545399B2 (en) |
CA (1) | CA1173388A (en) |
DE (2) | DE3033127A1 (en) |
DK (1) | DK149778C (en) |
ES (1) | ES8206448A1 (en) |
ZA (1) | ZA816085B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3327928A1 (en) * | 1983-08-03 | 1985-02-21 | Hoechst Ag, 6230 Frankfurt | METHOD FOR PRODUCING INSULIN DERIVATIVES |
DE3333640A1 (en) * | 1983-09-17 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | METHOD FOR THE PRODUCTION OF INSULIN DERIVATIVES, THE B-CHAIN C-TERMINAL EXTENDED, NEW BASICALLY MODIFIED INSULIN DERIVATIVES, THE MEANS CONTAINING THEM AND THEIR USE |
DK347086D0 (en) * | 1986-07-21 | 1986-07-21 | Novo Industri As | NOVEL PEPTIDES |
DE3837825A1 (en) * | 1988-11-08 | 1990-05-10 | Hoechst Ag | NEW INSULIN DERIVATIVES, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM |
CN1125081C (en) | 1999-09-08 | 2003-10-22 | 中国科学院上海生物化学研究所 | Recombined natural and new-type human insulin and its preparation |
DE10114178A1 (en) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinc-free and low-zinc insulin preparations with improved stability |
DE10227232A1 (en) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Sour insulin preparations with improved stability |
ES2650621T3 (en) | 2008-10-17 | 2018-01-19 | Sanofi-Aventis Deutschland Gmbh | Combination of an insulin and a GLP-1 agonist |
TWI468171B (en) | 2009-11-13 | 2015-01-11 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
PE20121362A1 (en) | 2009-11-13 | 2012-10-17 | Sanofi Aventis Deutschland | PHARMACEUTICAL COMPOSITION INCLUDING DESPRO36EXENDIN-4 (1-39) -LYS6-NH2, INSULIN GLY (A21) -ARG (B31) -ARG (B32) AND METHIONINE |
RU2546520C2 (en) | 2010-08-30 | 2015-04-10 | Санофи-Авентис Дойчланд Гмбх | Application of ave0010 for production of medication for treatment of type 2 diabetes mellitus |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
CN103917241A (en) | 2011-08-29 | 2014-07-09 | 赛诺菲-安万特德国有限公司 | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
RS64300B1 (en) | 2014-12-12 | 2023-07-31 | Sanofi Aventis Deutschland | Insulin glargine/lixisenatide fixed ratio formulation |
TWI748945B (en) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | Treatment type 2 diabetes mellitus patients |
TW201705975A (en) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | Treatment of type 2 diabetes mellitus patients |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3364116A (en) * | 1964-11-02 | 1968-01-16 | Squibb & Sons Inc | Method of use of desalanino insulin compositions |
DE2256215C3 (en) * | 1972-11-16 | 1981-01-08 | Hoechst Ag, 6000 Frankfurt | Insulin preparation containing crystalline insulin and amorphous desphenylalanine8 '-insulin |
-
1980
- 1980-09-03 DE DE19803033127 patent/DE3033127A1/en not_active Withdrawn
-
1981
- 1981-08-26 EP EP81106625A patent/EP0046979B1/en not_active Expired
- 1981-08-26 AT AT81106625T patent/ATE4591T1/en not_active IP Right Cessation
- 1981-08-26 DE DE8181106625T patent/DE3160852D1/en not_active Expired
- 1981-08-28 ES ES505039A patent/ES8206448A1/en not_active Expired
- 1981-09-01 JP JP56136212A patent/JPS5777655A/en active Pending
- 1981-09-02 DK DK388081A patent/DK149778C/en active
- 1981-09-02 AU AU74883/81A patent/AU545399B2/en not_active Ceased
- 1981-09-02 ZA ZA816085A patent/ZA816085B/en unknown
- 1981-09-02 CA CA000385067A patent/CA1173388A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK149778B (en) | 1986-09-29 |
ZA816085B (en) | 1982-08-25 |
CA1173388A (en) | 1984-08-28 |
EP0046979A1 (en) | 1982-03-10 |
ES505039A0 (en) | 1982-08-16 |
ES8206448A1 (en) | 1982-08-16 |
DK388081A (en) | 1982-03-04 |
DE3033127A1 (en) | 1982-04-08 |
ATE4591T1 (en) | 1983-09-15 |
JPS5777655A (en) | 1982-05-15 |
EP0046979B1 (en) | 1983-09-07 |
DK149778C (en) | 1987-04-06 |
DE3160852D1 (en) | 1983-10-13 |
AU545399B2 (en) | 1985-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU545399B2 (en) | Insulin analogues | |
HUT39046A (en) | Method for converting harvester from operating position, when the longitudinal axle of machine-body is transversal to the direction of work, into transport position, when the logitudinal axle of machine-body is parallel to the direction of work and harvesters using this method | |
IL57991A (en) | Propargyloximino-trimethylbicyclo(2,2,1)heptane,its preparation and plant growth regulating and insecticidal compositions containing it | |
JPS559089A (en) | Use of arylaminobenzoic acid as hypoglycemic and composition for said use | |
JPS54163812A (en) | Substituted benzorylthioalkanoic acid as plant growth regulating agent | |
DE2961070D1 (en) | N,n-dimethyl-o-pyrimidinyl-carbamic acid esters, process for their preparation and their use as pesticides | |
IL63211A0 (en) | 1-aryl-cyclopropane-1-carboxylic acid esters,their preparation and their use as pesticides | |
GB2157283B (en) | Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents | |
HUT38321A (en) | Herbicide compositions containing substituted carboxylic acid anilides as active substances and process for preparing the active substances | |
IL66193A0 (en) | S-azolylmethyl-di-(and-tri-)-thiophosphoric acid esters,their preparation and their use as pesticides | |
DE2960306D1 (en) | Alpha-isopropyl-phenylacetic acid esters, their preparation and use as pesticides | |
ZA792149B (en) | N,n-dimethyl-o-pyrazolyl-carbamic acid esters,processes for their preparation and their use as insecticides | |
IL86777A0 (en) | Plant treatment composition | |
IL57778A0 (en) | 2-cyclopropyl-pyrimidin-4-yl-thionophosphonic acid esters,their preparation and their use as insecticides and acaricides | |
AU6461590A (en) | ||
IL61418A0 (en) | Fluorine-substituted 2,2,3,3-tetramethyl-cyclopropane-1-carboxylic acid benzyl esters, their preparation and their use as pesticides | |
DE3568273D1 (en) | Trichloroacetortoxy-3,4,5,6-tetrachlorobenzoic acid chemoterapeutically active against cutaneous and subcutaneous benigne neoformations, process for its preparation and compositions conmtaining the same | |
IL58331A0 (en) | Substituted bromostyrl-cyclopropanecarboxylic acid phenoxybenzyl esters, their preparation and their use as insecticides and acaricides | |
DE3473276D1 (en) | 0,s-dialkyl-s-(carbamoyloxymethyl)-dithiophosphoric acid esters, process for their preparation as well as their use as pesticides | |
DE3262248D1 (en) | Cyclopropancarboxylic acid esters, their preparation and application as pesticides | |
DE2860733D1 (en) | (1,2,3,4,5,6h)-triazine-2,4-diones, method for their preparation and their use as insecticides | |
MN173A6 (en) | Triethanolamine salt of 2,4-chlorophenoxycetic acid as biological stimulant | |
IL83606A (en) | Esters of 3-(3-substituted-3,3-difluoro-1-propenyl)2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides | |
IL66304A0 (en) | Thionophosphonic acid esters,their preparation and their use as pesticides | |
ZA837658B (en) | Thiophosphonic acid esters,processes for their preparation and their use as agents for combating pests |